These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 11958642)
41. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. Porta C; Maiolo A; Tua A; Grignani G Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928 [TBL] [Abstract][Full Text] [Related]
42. Isolation of a phospholipid inhibitor of platelet activating factor-induced activity from perfused rat liver: identification as phosphatidylglycerol. Lekka M; Tokumura A; Tsuji H; Hanahan DJ Arch Biochem Biophys; 1993 May; 302(2):380-4. PubMed ID: 8489242 [TBL] [Abstract][Full Text] [Related]
44. Anti-platelet-activating factor, antibacterial, and antiradical activities of lipids extract from silver carp brain. Wang C; Xia W; Xu Y; Jiang Q; Yin S; Yang Y; Yu P Lipids Health Dis; 2013 Jun; 12():94. PubMed ID: 23805935 [TBL] [Abstract][Full Text] [Related]
45. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. Kornecki E; Ehrlich YH; Lenox RH Science; 1984 Dec; 226(4681):1454-6. PubMed ID: 6150550 [TBL] [Abstract][Full Text] [Related]
46. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances. Vargaftig BB; Joseph D; Marlas G; Chevance LG Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345 [TBL] [Abstract][Full Text] [Related]
47. The presence of platelet-activating factor-like activity in human spermatozoa. Minhas BS; Kumar R; Ricker DD; Robertson JL; Dodson MG Fertil Steril; 1991 Feb; 55(2):372-6. PubMed ID: 1991535 [TBL] [Abstract][Full Text] [Related]
48. Translocation-independent activation of protein kinase C by platelet-activating factor, thrombin and prostacyclin. Lack of correlation with polyphosphoinositide hydrolysis in rabbit platelets. Salari H; Duronio V; Howard S; Demos M; Pelech SL Biochem J; 1990 May; 267(3):689-96. PubMed ID: 2160234 [TBL] [Abstract][Full Text] [Related]
49. Occurrence of an endogenous inhibitor of platelet-activating factor in rat liver. Miwa M; Hill C; Kumar R; Sugatani J; Olson MS; Hanahan DJ J Biol Chem; 1987 Jan; 262(2):527-30. PubMed ID: 3804997 [TBL] [Abstract][Full Text] [Related]
50. Dietary supplementation of grape polyphenols and chronic ethanol administration on LDL oxidation and platelet function in rats. Xia J; Allenbrand B; Sun GY Life Sci; 1998; 63(5):383-90. PubMed ID: 9714425 [TBL] [Abstract][Full Text] [Related]
51. Anti-platelet activating factor property of Rubia cordifolia Linn. Tripathi YB; Pandey S; Shukla SD Indian J Exp Biol; 1993 Jun; 31(6):533-5. PubMed ID: 8406601 [TBL] [Abstract][Full Text] [Related]
52. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding. Herbert JM; Laplace MC; Maffrand JP J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264 [TBL] [Abstract][Full Text] [Related]
53. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies. Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624 [TBL] [Abstract][Full Text] [Related]
54. Lipid inhibitors of platelet-activating factor (PAF) in normal human plasma. Woodard DS; Ostrom KK; McManus LM J Lipid Mediat Cell Signal; 1995 Jul; 12(1):11-28. PubMed ID: 7551686 [TBL] [Abstract][Full Text] [Related]
55. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin. Wal F; Joseph D; Touqui L; Vargaftig BB Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525 [TBL] [Abstract][Full Text] [Related]
56. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding. Bin Z; Kun L Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795 [TBL] [Abstract][Full Text] [Related]
57. Platelet activating factor: an inhibitor of neutrophil activation? O'Donnell MC; Siegel JN; Fiedel BA Clin Exp Immunol; 1981 Jan; 43(1):135-42. PubMed ID: 7249391 [TBL] [Abstract][Full Text] [Related]
58. Isolation and identification of hydroxyl-platelet-activating factor from natural sources. Tsoupras AB; Antonopoulou S; Baltas G; Samiotaki M; Panayotou G; Kotsifaki H; Mantzavinos Z; Demopoulos CA Life Sci; 2006 Oct; 79(19):1796-803. PubMed ID: 16860827 [TBL] [Abstract][Full Text] [Related]
59. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712 [TBL] [Abstract][Full Text] [Related]
60. Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus. Antonopoulou S; Fragopoulou E; Karantonis HC; Mitsou E; Sitara M; Rementzis J; Mourelatos A; Ginis A; Phenekos C J Med Food; 2006; 9(3):356-62. PubMed ID: 17004898 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]